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Background: The role of mycobacterial infection, particularly related to Mycobacterium avium subsp
paratuberculosis (Map), in Crohn’s disease has long been debated. We developed primer pairs capable of
detecting a broad spectrum of mycobacterium and employed them to investigate surgical specimens from
patients with Crohn’s disease.
Methods: Pan mycobacterium primers of the 65-kDa heat shock protein gene (Hsp65) were used in a
polymerase chain reaction (PCR) to examine 12 surgically-resected, formalin-fixed, paraffin-embedded
specimens from 11 patients with Crohn’s disease. The DNA sequences of amplicons were aligned with those
in GenBank.
Results: Mycobacterial DNA was found in specimens from three of 11 patients. M. mucogenicum was identified
in a specimen from one patient and M. tuberculosis in two, but Map was not identified in any.
Conclusion: Hsp65-based PCR can be employed to search for occult mycobacterial infection of the
gastrointestinal tract in patients with a diagnosis or suspicion of Crohn’s disease. This approach may have a
therapeutic implication. [J Formos Med Assoc 2006;105(4):290–298]
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Crohn’s disease was initially reported as chronic
interstitial enteritis by Dalziel in 1913,1 and then
described as regional ileitis by Crohn in 1952.2
It is an idiopathic inflammatory bowel disease
characterized by noncaseating granulomas with
transmural inflammation. However, the resem-
blance of Crohn’s disease to paratuberculosis of
ruminants (Johne’s disease)3,4 implies that Myco-
bacterium avium subsp paratuberculosis (Map) may
cause Crohn’s disease in humans. This hypothe-
sis has prompted many investigators to determine
if Map can be detected in Crohn’s disease, parti-
cularly after the emergence of polymerase chain
reaction (PCR)-based techniques. So far, at least
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32 PCR-based studies of Crohn’s disease have
been reported. Among these, 18 studies have found
Map DNA,5–12 whereas 14 have reported negative
results.13–19 This discrepancy further adds to the
complexity of an already confused pathogenesis
of Crohn’s disease.
Several possible explanations have been pro-
vided for the possible false-negative findings.
First, sampling paucimicrobial tissue might yield
a DNA extract that contains insufficient template
for detection by PCR assay. Second, suboptimal
procedures, such as inadequate disruption of bac-
terial walls and the presence of inhibitors for en-
zyme reactions, might result in detection failure.
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polymorphism of the mycobacterial cell wall
65-kDa heat shock protein gene (Hsp65) can dis-
tinguish a broad spectrum of mycobacterium,
and then applied this technique to determine if
mycobacteria other than Map could be detected
in the surgical specimens of patients with Crohn’s
disease.
Methods
All patients with a diagnosis of Crohn’s disease
between 1992 and 2003 were identified from the
files of the Department of Pathology, Mackay
Memorial Hospital, Taipei. This study was con-
ducted according to the guidelines of the hospi-
tal’s institutional review board. The final study
group comprised 12 specimens from 11 patients
(Table 1). Each had typical features of Crohn’s
disease, including clinical presentation, imaging
profiles, and histopathologic features. The histo-
Third, some PCR products may contain too little
DNA to be visualized unless sensitive methods
such as hybridization with isotope-labeled probes
or amplification by nested PCR are employed. It
has been noted, however, that most of the report-
ed PCR assays targeting the repetitive IS900 in-
sertion element in the Map genome20,21 were very
sensitive, particularly when nested PCR was
employed. Therefore, the negative or low yield of
positive samples probably implies that no (or an
insignificant percentage of) patients with Crohn’s
disease were infected with Map.
We speculated that the geographic variation of
mycobacteria may provide an additional explana-
tion for this discrepancy. There is no evidence to
suggest that Map is the only species of mycobacte-
rium that can cause Crohn’s disease. In addition,
Johne’s disease is, in fact, morphologically simi-
lar to M. avium intracellular infection rather than
to Crohn’s disease.22 To test this hypothesis, we
first investigated whether the nucleotide sequence
Table 1. Summary of patients diagnosed with Crohn’s disease
Case Presentation, treatment and outcome
1 35-year-old female with right lower quadrant pain, a palpable mass and leukocytosis; treated by segmental resection of the
cecum and terminal ileum; postoperative intestinal obstruction managed by exploratory laparotomy and lysis of adhesion
2 50-year-old male with ileus and a plain abdominal film showed small bowel dilation with gas retention
3 35-year-old female with intermittent right lower quadrant pain; computed tomography showed an appendiceal abscess with local
extension into the right psoas-iliac muscles; treated by segmental resection
4 49-year-old female with chronic diarrhea for 2 years; treated by segmental resection of the small intestine and oral prednisolone;
postoperative complications included enterocutaneous fistula, occasional diarrhea, malnutrition, and osteoporosis
5 41-year-old male with a 1-year history of chronic diarrhea, tarry stool and body weight loss; fistula formation in the resected
small bowel
6 27-year-old male with a 1-month history of left lower quadrant pain and change in bowel habit; roentgenography showed
paralytic ileus with segmental narrowing at the junction between the ileum and jejunum; treated by resection of the ileum
7 64-year-old male with abdominal discomfort initially treated by segmental resection of the cecum and ascending colon; persistent
enterocolitis and complications (adhesions, fistulae) treated by numerous abdominal surgeries; diagnosis of Crohn’s disease made
after a right hemicolectomy during his third hospitalization; prednisolone prescribed intermittently
8 40-year-old male with hollow organ perforation; treated by sigmoid colectomy and ileal resection; died of pneumonia and sepsis
9 49-year-old male with intermittent abdominal pain; treated by partial colectomy, resection of the ileum and oral prednisolone
10 35-year-old male with a 4-year history of diarrhea; treated by right hemicolectomy; symptoms recurred 5 years later and treated
by ileoileal bypass
11 22-year-old male with abdominal pain, vomiting and tarry stool; ileal resection for a perforation at the distal ileum; postoperative
complications included functional bowel disturbance and constipation
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pathologic features included evidence of trans-
mural chronic inflammation with multiple lym-
phoid aggregates and germinal centers, submuco-
sal fibrosis, lymphatic dilatation, muscular hyper-
trophy, and submucosal neuronal hyperplasia.
Some specimens also showed ulceration, micro-
abscess along the fistular tract, and small granulo-
mas in the mesenteric lymph nodes. Acid-fast stain
showed no stainable bacilli in all paraffin sections,
and all four specimens that were originally cultured
were negative for mycobacteria.
DNA isolation
Both the surgical margin with normal histopatho-
logy and the areas exhibiting granulomatous in-
flammation in hematoxylin and eosin-stained
sections of each specimen were circled with a mark-
ing pen for DNA extraction. DNA was extracted
from formalin-fixed tissue according to previously
described procedures.23 In brief, representative
paraffin blocks were cut at 8 μm using a clean
disposable microtome blade for each block. The
first and the last sections from each ribbon were
subjected to light microscopic examination after
routine hematoxylin and eosin staining.
The paraffin sections were transferred directly
into the PCR tubes and incubated in 300 μL of
xylene at 25°C for 5 minutes, pelleted at 12,000g
for 5 minutes, resuspended in 300 μL of absolute
alcohol at room temperature, spun down, and
lyophilized. The pellets were then processed using
the PUREGENETM DNA isolation kit (Gentra
Systems Inc, Minneapolis, MN, USA) according to
the manufacturer’s instructions, which includes
proteinase K (300 μg/mL) digestion overnight
at 55°C. The final extracts were dissolved in TE
buffer and kept at 4°C for later use.
PCR
The primers used to amplify the Hsp65 gene
(Figures 1 and 2), the recA gene and the rpoB gene
are shown in Table 2. PCR was carried out in
a DNA thermal cycler (GeneAmp PCR System
9600; Perkin-Elmer, Foster City, CA, USA). The re-
action mixtures consisted of 0.5 μg of extracted
DNA, 200 pmol of each of the oligonucleotide
primers, 200 μM of each deoxynucleotide triphos-
phate (Boehringer Mannheim, Indianapolis, IN,
USA), 1.5 mM MgCl2, 1.25 U of Taq polymerase
(AmpliTaq GoldTM DNA polymerase; Perkin-
Elmer Cetus, Norwalk, CT, USA), 5 μL of 10× PE
reaction buffer (500 mM KCl, 150 mM Tris-HCl
[pH 8.0]), and high-pressure liquid chromato-
graphy-grade distilled water in a total volume of
50 μL. The reaction protocol, performed in a mi-
crocentrifuge tube, was as follows: (1) denatura-
tion at 95°C for 10 minutes; (2) amplification for
45 cycles at 94°C for 1 minute, 60°C for 1 minute,
and 72°C for 1 minute; and (3) extension at 72°C
for 10 minutes.
DNA sequencing and sequence analysis
The PCR products were sequenced using the
ABI PRISM BigDye terminator cycle sequencing
ready reaction kit and ABI PRISM 377 genetic ana-
lyzer (PE Applied Biosystems, Foster City, CA,
USA). Hsp65 sequences among various species
of mycobacterium were retrieved from GenBank
(http://www.ncbi.nlm.nih.gov). The accession
numbers for these sequences are listed in Figure
2. Sequence analysis was performed using Vector
NTI Suite 8 software (InforMax Inc, Frederick, MD,
USA).
Results
Hsp65, first cloned from M. tuberculosis and se-
quenced in 1987,24 is present in a wide range of
Table 2. Primers used in PCR to amplify the Hsp65, recA and
rpoB genes
Hsp65
Hsp65-A1 5’-ATG GTG TGT CCA TCG CCA AG-3’
Hsp65-B1 5’-CGC ATA CCC TCG GTG AGC TC-3’
recA
recA-1 5’-AAG AGA CCC GCC AAC CGA TT-3’
recA-2 5’-CAT GTC GGC GAT CTC CAG GG-3’
rpoB
rpoB-1 5’-GCG AGC TGA TCC AGA ACC AGA T-3’
rpoB-2 5’-ATC AGA CCG ATG TTC GGG CCT T-3’
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mycobacterial species. To analyze the nucleotide
polymorphism of Hsp65 sequences, 87 strains
of mycobacterium were retrieved from GenBank
and aligned. The results showed a 424-bp seg-
ment containing a stretch of highly polymorphic
sequences flanked by conserved regions, which
are suitable for designing PCR primers (Figure
1). Furthermore, only 15 of 3828 (87 × 88/2) com-
parisons could not be distinguished from each
other by DNA sequence analysis (Figure 2). More
specifically, these 15 indistinguishable 424-bp
sequences could be divided into three identical
groups: M. farcinogenes (AF547830) vs. M. sene-
galense (AF547872); M. genavense (AF547837) vs.
M. heckeshornense (AF547843); and among M.
tuberculosis (AF547885), M. bovis (AF547884,
AF547813), M. microti (AF547856) and M.
africanum (AF547803). Therefore, this analysis
suggests that the 424-bp segment within the
Hsp65 sequence can be used to distinguish the
majority of mycobacteria, supporting its qualifi-
cation for the present study.
For each surgical specimen, DNA was sepa-
rately extracted from both the granulomatous le-
sion and the normal tissue at the surgical margin,
the latter of which served as a negative control.
Figure 1. Comparison of the DNA sequences of the 65-kDa heat shock protein gene (Hsp65) of 87 mycobacterial strains (accession numbers shown on
left) shows highly conserved flanking regions, which were used for PCR primers, designated Hsp65-A1 and Hsp65-B1. The consensus sequences,
labeled as solid boxes in the field, are listed at the bottom of the figure.
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Of the 12 specimens tested, three yielded PCR
products specific to Hsp65 that were visible under
ultraviolet light on ethidium bromide stained
agarose gel after electrophoresis (Figure 3). These
PCR products were produced from DNA extracted
from granulomatous lesions in specimens #7b,
#8 and #11. In contrast, DNA extracted from the
tissues at the surgical margin of each specimen
yielded no PCR products (data not shown). Hu-
man `-globin gene could be amplified from all
24 DNA specimens, indicating successful extrac-
tion of DNA (data not shown).
All PCR products were sequenced and ana-
lyzed. Search of the GenBank database revealed
that the amplicon sequences of specimens #7b
and #8 were M. tuberculosis (99.7%) and that of
Figure 2. DNA sequence homology among 87 strains of mycobacterium. Each number represents the homology between two species/subspecies
of mycobacterium, which are listed at the top and right side of the figure. Comparisons with 100% homology are boxed to highlight the identical
Hsp65 sequences between two species. (Mycobacterium species and corresponding access numbers listed in the left lower quadrant of the
figure for cross-reference.)
Figure 3. PCR-based detection of mycobacterial DNA from formalin-fixed,
paraffin-embedded tissue. DNA templates extracted from the paraffin-embedded
tissue were subjected to PCR for Hsp65. They yielded PCR products about 300 bp
in size (arrow). The PCR products of each case are labeled on the top of the gel.
Specimens #7a and #7b were collected from the same patient at different
operations. M = molecular weight marker (100 bp); N = negative control;
P = positive control from a known tuberculosis case.
M 1 2 3 4 5 6 7a 7b 8 9 10 11 N P M
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specimen #11 was M. mucogenicum (97.5% simi-
lar to AF547858; 98.6% to strains AF071135 and
AJ307637) (Figure 4). To further substantiate the
identified species from specimen #11, we exam-
ined two separate genes, recA and rpoB. The results
showed that the 302-bp PCR product of recA was
98% similar to two known strains (AY286457 and
AY286458) of M. mucogenicum (Figure 5A), and
the 346-bp PCR product of rpoB was 99% similar
to four known strains (AY147171, AY544946,
Figure 4. Case 11: (A) sequence chromatogram of Hsp65 amplicon; (B) sequence alignment with three strains of Mycobacterium
mucogenicum (AJ307637, AF547858, AF071135). The shaded nucleotides indicate consensus sequences.
AY147170, AY147174) of M. mucogenicum (Figure
5B).
Discussion
The development of techniques for using formalin-
fixed, paraffin-embedded specimens for PCR25
has offered an opportunity to retrospectively ex-
amine if an occult mycobacterial infection is asso-
  B
  A
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Figure 5. Alignment of (A) recA and (B) rpoB amplicons with the counterparts of known strains of Mycobacterium mucogenicum.
The shaded nucleotides indicate consensus sequences.
ciated with an inflammatory disease. The present
study has further demonstrated that identification
of mycobacterium species is also possible by ana-
lyzing the DNA sequence polymorphism of Hsp65.
Using this approach, we found that three of 11
cases of previously diagnosed Crohn’s disease
were associated with mycobacterial infection. The
identified species was M. mucogenicum in one and
M. tuberculosis in two, indicating that the designed
Hsp65-based PCR can detect a broad spectrum of
mycobacterium species in one reaction. Identifi-
cation of the mycobacterium species involved in a
given disease has important implications for
treatment. The intrinsic problem of using such a
broad spectrum primer pair is the associated low
specificity, but this can be easily solved by DNA
sequencing.
This is the first report of data showing an as-
sociation between Crohn’s disease and M. muco-
genicum. This organism was designated as a
new species in 1995 to replace the formerly named
M. chelonae-like organism.26 It belongs to the
M. fortuitum complex and has been implicated in
a number of nosocomial infections. It was initial-
ly isolated in 1982 from an outbreak of peritoni-
tis,27 and was later proved to be responsible for
bacteremia28–30 and central venous line-associated
sepsis.31 Recently, M. mucogenicum was shown to
have caused granulomatous hepatitis in an au-
topsy case,32 indicating that it can induce granulo-
matous inflammation in the digestive system. In
this study, tissues at the surgical margin of the
resected bowel were used as controls. This would
exclude the possibility of contamination, which
  B
  A
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is a concern because M. mucogenicum has been a
common contaminant in some laboratories.
We also identified two cases of tuberculosis
(Cases 7 and 8), suggesting that ileocecal tuber-
culosis and Crohn’s disease could be confusingly
similar in terms of clinical and pathologic mani-
festations. Without the aid of modern PCR-based
diagnosis, these cases would typically be diag-
nosed and treated as Crohn’s disease due to the
lack of caseous necrosis in the granulomas, nega-
tive acid-fast stain, and no growth of mycobacte-
ria in culture. This result is in accordance with our
previous findings that histopathologic variations
of tuberculosis are fairly common and cause sig-
nificant confusion or delay in diagnosis.25 There-
fore, for those cases with atypical morphology
and negative stain/culture of acid-fast bacilli, PCR
and DNA sequence analysis are the only available
methods for distinguishing these diseases. A pre-
vious study showed that a PCR-based diagnostic
method is capable of detecting 10 fg (equivalent
to about 2 mycobacterial genomes) in a reaction,33
and nine organisms of M. tuberculosis in a 5-μm
section of paraffin-embedded specimen.34
Over a period of 12 years (1992–2003), 11
patients were diagnosed with and treated for
Crohn’s disease in this medical center, yielding a
rough estimate of the annual incidence of Crohn’s
disease of about 0.78 per million population in
Taiwan. This is considerably lower than that in the
United States, where an annual incidence of 3
per 100,000 has been reported.35 The disparity of
incidences in various geographic regions could
be due to a number of reasons, such as underdiag-
nosis of Crohn’s disease in Taiwan or excluding
those without a clearly identifiable etiology. If
Crohn’s disease is intended to be considered as
a purely idiopathic disease of the bowel, the three
cases with identifiable mycobacteria in this study
should be excluded, which would yield an even
lower estimated incidence of Crohn’s disease in
Taiwan. Since mycobacterial infection is a poten-
tially curable disease, exclusion of those lesions
associated with mycobacterial infection from
Crohn’s disease seems reasonable. The routine
use of Hsp65-based PCR to exclude the possibility
of mycobacterial infection for every case with a
diagnosis or suspicion of Crohn’s disease is rec-
ommended.
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